Loading…
Gujarat Terce Laboratories (BSE 524314)₹45.02−2.76%Pharmaceuticals
At the end of the Jun 2026 quarter, Gujarat Terce Laboratories' shareholders were: promoters 39.97%, public 60.03%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 13,752 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 36.72% | 36.95% | 36.97% | 36.97% | 36.97% | 36.97% | 36.97% | 36.97% | 36.97% | 39.97% | 39.97% | 39.97% |
| Public | 63.28% | 63.05% | 63.03% | 63.03% | 63.03% | 63.03% | 63.03% | 63.03% | 63.03% | 60.03% | 60.03% | 60.03% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 13,401 | 13,324 | 13,200 | 13,391 | 13,535 | 13,707 | 13,761 | 13,801 | 13,809 | 13,802 | 13,747 | 13,752 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Aalap Natubhai Prajapati | Promoter | 17.41% | 0.00 |
| Abundant Trade Link Private Limited | Promoter | 13.85% | 0.00 |
| Natwarbhai Parsottam Prajapati | Promoter | 8.17% | 0.00 |
| Sagar Saxena | Public | 1.34% | 0.00 |
| Ganesh Vetrivel Periasamy | Public | 1.24% | +0.01 |
| Dheeraj Kumar Lohia | Public | 1.03% | 0.00 |
| Rishabh Negi | Public | 1.00% | New |
| Amritbhai P. Prajapati | Promoter | 0.40% | 0.00 |
| Shobhanaben Natvarbhai Prajapati | Promoter | 0.21% | 0.00 |
| Shachi Ravi Oza | Promoter | 0.10% | 0.00 |
Promoters held 39.97% of Gujarat Terce Laboratories at the end of the Jun 2026 quarter, up 3.00 percentage points from 36.97% a year earlier.
No. The Jun 2026 filing shows no pledged promoter shares.
Gujarat Terce Laboratories had 13,752 shareholders at the end of the Jun 2026 quarter, against 13,801 a year earlier.
Sagar Saxena (Public) held 1.34% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.